Source 1primary paper2025MED
Toolkit/dynamic light scattering
dynamic light scattering
Also known as: DLS
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
This study aimed to use dynamic light scattering (DLS) for monitoring EV71 particle size... The DLS technique was validated.
Usefulness & Problems
Why this is useful
DLS is presented as an optical method for real-time, noninvasive monitoring of microbes in bioaerosol detection contexts.; real-time monitoring of microbes; noninvasive monitoring of microbes; Dynamic light scattering was used to monitor EV71 particle size and detect aggregation changes under stress conditions. The abstract states that the DLS technique was validated and showed robust performance.; monitoring EV71 particle size; monitoring viral particle aggregation under formulation stress
Source:
DLS is presented as an optical method for real-time, noninvasive monitoring of microbes in bioaerosol detection contexts.
Source:
real-time monitoring of microbes
Source:
noninvasive monitoring of microbes
Source:
Dynamic light scattering was used to monitor EV71 particle size and detect aggregation changes under stress conditions. The abstract states that the DLS technique was validated and showed robust performance.
Source:
monitoring EV71 particle size
Source:
monitoring viral particle aggregation under formulation stress
Problem solved
It helps provide faster and noninvasive monitoring of airborne microbial signals.; supports real-time microbe detection; It provides a way to monitor aggregation-related stability of inactivated EV71 vaccine particles for formulation and quality-control work.; provides a method to assess EV71 particle aggregation stability
Source:
It helps provide faster and noninvasive monitoring of airborne microbial signals.
Source:
supports real-time microbe detection
Source:
It provides a way to monitor aggregation-related stability of inactivated EV71 vaccine particles for formulation and quality-control work.
Source:
provides a method to assess EV71 particle aggregation stability
Problem links
provides a method to assess EV71 particle aggregation stability
LiteratureIt provides a way to monitor aggregation-related stability of inactivated EV71 vaccine particles for formulation and quality-control work.
Source:
It provides a way to monitor aggregation-related stability of inactivated EV71 vaccine particles for formulation and quality-control work.
supports real-time microbe detection
LiteratureIt helps provide faster and noninvasive monitoring of airborne microbial signals.
Source:
It helps provide faster and noninvasive monitoring of airborne microbial signals.
Published Workflows
Objective: Produce FPV VP2-based virus-like particles using a recombinant baculovirus expression system and evaluate their immunogenicity and protective efficacy in cats.
Why it works: The workflow first generates and confirms assembled FPV VLPs, then tests whether those particles induce antibody responses and protect cats from virulent challenge. The paper frames this as a route to a safer and more efficient alternative to current vaccines.
VP2-based self-assembly into virus-like particlesinduction of HI and virus-neutralizing antibody responsesrecombinant baculovirus expression in Sf9 cellsprotein purification by ultrafiltration and SECparticle characterization by DLS and TEManimal immunization and virulent challenge
Stages
- 1.VLP production and purification(library_build)
This stage generates the FPV VP2 material needed to form the vaccine candidate before characterization and animal testing.
Selection: Expression of VP2 in Sf9 insect cells followed by purification of VP2 material.
- 2.Particle assembly confirmation(functional_characterization)
This stage verifies that the expressed and purified VP2 formed virus-like particles before proceeding to animal immunization.
Selection: Confirmation of VLP assembly by DLS and TEM.
- 3.Cat immunization and serologic readout(secondary_characterization)
This stage tests whether the VLP vaccine induces measurable antibody responses in the target animal species before challenge.
Selection: Comparison of HI and VN antibody responses between vaccinated and PBS control cats.
- 4.Virulent challenge validation(confirmatory_validation)
This stage confirms whether vaccination translates into protection against virulent FPV infection in cats.
Selection: Protection from clinical signs and maintenance of white blood cell counts after virulent FPV strain 708 challenge.
Steps
- 1.Express VP2 in Sf9 insect cells using recombinant baculovirusengineered vaccine material being produced
Generate FPV VP2 protein for VLP formation.
VP2 expression is required before purification, assembly confirmation, and animal testing can occur.
- 2.Purify VP2 material by ultrafiltration and SECvaccine material being purified
Obtain purified VP2/VLP material for downstream assembly confirmation and immunization.
Purification follows expression so that the material can be characterized and used as vaccine input.
- 3.Confirm VLP assembly by DLS and TEMvaccine construct being characterized
Verify that the purified VP2 material formed virus-like particles.
Assembly confirmation is performed before animal immunization to ensure the intended VLP product was generated.
- 4.Immunize cats with three VLP dose levels and collect day-21 blood samplesvaccine administered to animals
Test dose-dependent immunization in cats and prepare for serologic assessment.
Animal dosing must precede antibody measurement and challenge testing.
- 5.Measure HI and VN antibody responsesassays used to evaluate vaccine response
Assess immunogenicity of the FPV VLP vaccine before challenge.
Serologic testing follows immunization and provides a pre-challenge readout of vaccine-induced antibody responses.
- 6.Challenge the 15 bcg dose group with virulent FPV strain 708 and monitor disease outcomesvaccine previously administered to challenged animals
Determine whether vaccination protects cats from virulent FPV disease.
Challenge is performed after immunization and serologic assessment to test whether the vaccine confers functional protection.
Objective: Use dynamic light scattering to monitor EV71 particle size, evaluate how environmental stresses affect viral aggregation, and identify stabilizing agents that inhibit stress-induced aggregation.
Why it works: The workflow uses a validated DLS readout to monitor particle-size changes while systematically varying stress and formulation conditions, enabling identification of conditions and additives that reduce aggregation.
inhibition of stress-induced viral particle aggregationdynamic light scatteringenvironmental stress testingstabilizer screening
Stages
- 1.DLS method validation(confirmatory_validation)
The DLS technique was validated before being used to assess stress effects and stabilizer performance.
Selection: robust performance of the DLS method for EV71 particle-size monitoring
- 2.Environmental stress assessment(functional_characterization)
This stage identifies which environmental conditions promote or avoid EV71 particle aggregation.
Selection: measure effects of pH, ionic strength, freeze-thaw cycles, temperature, and mechanical stresses on viral particle size
- 3.Buffer salt and stabilizer evaluation(secondary_characterization)
After identifying stress effects, the study systematically evaluates additives that can mitigate aggregation under those stresses.
Selection: compare buffer salts and stabilizers for inhibition of stress-induced aggregation
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
light scatteringTechniques
Functional AssayTarget processes
No target processes tagged yet.
Input: Light
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: spectral hardware requirementoperating role: sensor
The abstract supports that it requires an optical sensing setup.; requires optical detection setup; The method requires inactivated EV71 particle samples and defined environmental or formulation conditions such as pH, temperature, stirring, buffer salts, or stabilizers.; requires EV71 particle samples exposed to defined stress or formulation conditions
The abstract does not show that DLS alone identifies the structural mechanism of aggregation or replaces orthogonal particle characterization methods.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Source 2primary paper2026MED
Ranked Claims
DLS, MFS, and HSI enable real-time, noninvasive monitoring of microbes.
Self-disinfecting filtration membranes treated with silver nanoparticles, TiO2, or enzymes are highly efficient and in use for bioaerosol filtration.
MOFs, COFs, and carbon-based nanostructures can trap airborne microbes and neutralize them through photocatalytic or oxidative reactions.
Dynamic light scattering was validated and showed robust performance for monitoring EV71 particle size and aggregation.
The DLS technique was validated... The DLS method exhibited robust performance.
Approval Evidence
2 sources2 linked approval claimsfirst-pass slug dynamic-light-scattering
Optical methods such as dynamic light scattering (DLS) ... enable real-time, noninvasive monitoring of microbes.
Source:
This study aimed to use dynamic light scattering (DLS) for monitoring EV71 particle size... The DLS technique was validated.
Source:
capabilitysupports
DLS, MFS, and HSI enable real-time, noninvasive monitoring of microbes.
Source:
method performancesupports
Dynamic light scattering was validated and showed robust performance for monitoring EV71 particle size and aggregation.
The DLS technique was validated... The DLS method exhibited robust performance.
Source:
Comparisons
Source-stated alternatives
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.; No explicit alternative assay is named in the abstract.
Source:
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.
Source:
No explicit alternative assay is named in the abstract.
Source-backed strengths
real-time; noninvasive; exhibited robust performance; was used across multiple environmental stress conditions
Source:
real-time
Source:
noninvasive
Source:
exhibited robust performance
Source:
was used across multiple environmental stress conditions
Compared with biosensors
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: real-time; noninvasive; exhibited robust performance.
Source:
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.
Compared with biosensors for active Rho detection
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: real-time; noninvasive; exhibited robust performance.
Source:
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.
Compared with fluorescent protein based reporters and biosensors
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: real-time; noninvasive; exhibited robust performance.
Source:
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.
Compared with genetically engineered biosensors
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.
Shared frame: source-stated alternative in extracted literature
Strengths here: real-time; noninvasive; exhibited robust performance.
Source:
The abstract names MFS, HSI, and electrochemical biosensors as alternative detection approaches.
Ranked Citations
- 1.
- 2.